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Abstract
Background: Cancer in the sinonasal tract is rare, but persons who have been occupationally
exposed to wood dust have a substantially increased risk. It has been estimated that approximately
3.6 million workers are exposed to inhalable wood dust in EU. In previous small studies of this
cancer, ras mutations were suggested to be related to wood dust exposure, but these studies were
too limited to detect statistically significant associations.
Methods: We examined 174 cases of sinonasal cancer diagnosed in Denmark in the period from
1991 to 2001. To ensure uniformity, all histological diagnoses were carefully reviewed
pathologically before inclusion. Paraffin embedded tumour samples from 58 adenocarcinomas, 109
squamous cell carcinomas and 7 other carcinomas were analysed for K-ras codon 12, 13 and 61
point mutations by restriction fragment length polymorphisms and direct sequencing. Information
on occupational exposure to wood dust and to potential confounders was obtained from
telephone interviews and from registry data.
Results: Among the patients in this study, exposure to wood dust was associated with a 21-fold
increased risk of having an adenocarcinoma than a squamous cell carcinoma compared to
unexposed [OR = 21.0, CI = 8.0–55.0]. K-ras was mutated in 13% of the adenocarcinomas (seven
patients) and in 1% of squamous cell carcinomas (one patient). Of these eight mutations, five
mutations were located in the codon 12. The exact sequence change of remaining three could not
be identified unambiguously. Among the five identified mutations, the G→A transition was the most
common, and it was present in tumour tissue from two wood dust exposed adenocarcinoma
patients and one patient with unknown exposure. Previously published studies of sinonasal cancer
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exposure.
Conclusion: Patients exposed to wood dust seemed more likely to develop adenocarcinoma
compared to squamous cell carcinomas. K-ras mutations were detected in 13% of
adenocarcinomas. In this study and previously published studies of sinonasal cancer the found K-
ras mutations, were almost exclusively G → A transitions. In conclusion, our study, based on a large
representative collection of human SNC tumours, indicates that K-ras mutations are relatively
infrequent, and most commonly occur in adenocarcinomas. Wood dust exposure alone was not
found to be explanatory for the G→A mutations, but combination of exposure to tobacco, wood
dust, and possibly other occupational agents may be a more likely explanation. Overall, the study
suggests a limited role for K-ras mutations in development of sinonasal cancer.
Background
Cancer of the sinonasal cavities is rare with an annual
standardized incidence rate of 0.46 per 100 000 person-
years for men and 0.62 for women in Denmark year 2001
[1]. In 1967, Acheson et al. reported of a cluster of patients
with sinonasal adenocarcinomas in the furniture industry
in Buckinghamshire, Great Britain [2]. Since then, several
studies have found an association between exposure to
wood dust and sinonasal cancer [3-5]. In particular, aden-
ocarcinoma has been strongly associated with exposure to
hardwood dust [6]. In a recent reanalysis of 12 pooled
studies, an odds ratio of 45.5 [CI = 28.3–72.9] for adeno-
carcinoma was found among male workers occupied in
jobs with high levels of wood dust exposure [7]. The Inter-
national Agency for Research on Cancer (IARC) classified
"furniture and cabinet making" as carcinogenic to
humans in 1987 and so was wood dust in 1995 [8].
Mutagenic carcinogens can leave fingerprints such as spe-
cific mutation patterns, which may help identify them as
environmental risk factors [9]. Because tumour suppres-
sor genes and oncogenes are involved in carcinogenesis,
they are good candidates for such investigations. One of
the most well established links between a pattern of muta-
tion and environmental exposure is ultraviolet light
induced mutation in the p53 gene. UV-light damages
DNA by the formation of dipyrimidine adducts between
two adjacent pyrimidines. This adduct is converted to a
unique UV induced transition, the CC→TT tandem muta-
tion, which is detected at high frequencies in human skin
cancers [10-12]. It is thus a fingerprint of UVB induced
DNA damage.
Mutations in the activating codons of ras (12, 13 and 61)
are detected in 20–30% of all human cancers, varying in
frequency between the different organs. E.g. < 90% of
pancreas cancers harbour ras mutations [13]. Codon 12 is
a preferential site for DNA adduct formation for several
carcinogens [14]. Smoking may be contributing to sinon-
asal cancer. Lung cancers from smokers frequently har-
bours mutations in the ras gene codon 12 [15], the most
frequent type of mutations is a G•C→T•A transversion in
K-ras codon 12 [16]. The benzo(a)pyrene diol-epoxide-
guanine adduct, that is most frequently produced when
benzo(a)pyrene metabolites reacts with DNA, has been
identified in the lungs of smokers[17]. This adduct is most
frequently transformed into G•C to T•A transversions
[17]. The nitrosamine NNK, a tobacco-specific lung car-
cinogen, is associated with G•C → A•T transitions in
rodent lung tumours [18]. Among non-smokers with lung
cancer the G•C → A•T transition is the most frequent
point mutation [15].
Genetic changes in sinonasal adenocarcinomas have been
reported occasionally. Studies including a limited number
of patients indicate, that the ras genes are mutated in some
tumours [19-22]. In the studies of Saber et al [20] and
Yom et al [21], K-ras was mutated in approximately 14%
of the tumours. In the study of Spanish intestinal-type
adenocarcinomas, 50% of the tumours harboured muta-
tions [23]. The G•C → A•T transition was among the most
common mutations found, but interpretation of the
results has been limited due to the small sample sizes.
These previous studies indicated that wood dust exposure
might be correlated to a specific mutation pattern.
Methods
Study subjects and tumour material
This study was reviewed and approved by the Danish
National Committee on Biomedical Research Ethics
(journal number: KF 01-048/02). Records on potential
study subjects with sinonasal cancer were retrieved from
the nationwide Danish Cancer Registry. This computer-
ized register, which is regarded as almost complete, uses
the unique Central Person Registry Number (CPR) as the
key identifier of each patient. This CPR-number is applied
to all citizens in Denmark, and is used all over the society
for administrative identification of persons. It includes
information on name and address, vital status, dates of
eventual decease or emigration, and to some extent on rel-
atives. From the start of the Danish Cancer registry in
1942 an extended version of the 7th revised of the Inter-Page 2 of 11
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been used for classification of cancers. Since 1978
tumours have also been classified according to the Inter-
national Classification of Disease for Oncology, including
detailed information of topography and morphology [1].
By use of a combination of the two classification schemes
we selected records of the in total 466 patients born after
1903 and registered with adenocarcinomas or squamous
cell carcinomas between 1991 and 2001, with ICD7 code
160.
The inclusion criteria for study were, that the tumour
should be located in the nasal cavity or paranasal sinuses,
and only the diagnoses listed in Table 1, were included in
the study. Among the initial 466 patient retrieved form
the cancer registry 11 were excluded because there was
unequivocal information on the notifying hospital and
the patients was not treated in the university hospitals,
therefore no pathological information could be retrieved.
An additional 32 study subjects were excluded because the
pathology reports were missing in the hospital archives.
For the remaining 423 study subjects we received one or
more pathology reports. On the basis of the entire infor-
mation in these reports, 215 patients were excluded
because the diagnoses did not comply with our inclusion
criteria. A major part of the excluded tumours was located
in the vestibulum nasi or in the nasopharynx. If a report
was not accurate enough to include or exclude a study
subject, we retrieved paraffin embedded tumour samples
(PET) and original sections. These were then evaluated by
our pathologists resulting in exclusion of an additional 34
patients. One of these patients was excluded because the
tumour block contained less than 10% tumour tissue. The
remaining 174 study subjects were included in the present
study (Table 1).
Tissue samples
PET blocks were sectioned serially to prepare material for
pathological review and molecular analysis: For the his-
topathological review, one section was stained with
hematoxylin and eosin and one with alcien blue-PAS.
Two times five 10-μm sections were collected for DNA
extraction. A final section was cut for hematoxylin and
eosin staining to confirm that there was tumour tissue in
the intervening sections. On review the ratio of tumour
cells to non-malignant cells in the tissue sections was esti-
mated. In a few cases additional sections were cut for
automated immunohistochemical staining.
Review of the histological diagnoses
To ensure uniform tumour classification according to
modern criteria, the slides were coded and histological
diagnoses were evaluated independently by two of us
(M.D. and T.S) without knowledge of the original diagno-
sis. Both reviewers assigned a concordant diagnosis in
almost all cases. For a few in which there was disagree-
ment, both reviewers re-examined the slides in concert to
reach consensus. In seven cases, immunohistochemical
staining was performed to determine the final diagnosis.
Table 1: A detailed list of histological diagnoses included in the molecular epidemiology study, with reference to the WHO 
classification of tumours (WHO, 1991). SNOMED, Systemic Nomenclature of Medicine and the distribution of the histology of the 
samples.
WHO code SNOMED 1991 Diagnosis Comments Subtype Distribution in the 
study
1.2.1 8121/3 Sinonasal carcinoma SNUC, refer to IHC Not othervice specified
Undifferentiated
6
1
1.2.1.1 8070/3 Squamous cell carcinoma keratinising and 
nonkeratinising
associated with inverted 
papilloma
104
3
1.2.1.2 8121/3 Cylindrical cell carcinoma -
1.2.2 8051/3 Verrucous squamous cell 
carcinoma
2
1.2.3 8074/3 Spindle cell carcinoma -
1.2.4 8140/3 Adenocarcinoma Low grade
low grade – acinic like
high grade
11
1
22
1.2.5 8260/3 Papillary adenocarcinoma 1
1.2.6 8144/3 Intestinal-type 
adenocarcinoma
23
1.2.18 8041/3 Small cell carcinoma Probably metastasis from 
primary lung tumour
-
1.2.19 8082/3 Lymphoepithelial 
carcinoma
-
1.2.15 8560/3 Adenosquamous 
carcinoma
-Page 3 of 11
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Three different sources were used to obtain information
on exposure to wood dust and other potential risk factors.
First, all study subjects were retrieved based on the CPR-
number in the computerized National Pension Fund, for
which membership has been compulsory for all wage
earners in Denmark since the start of this scheme in 1964.
This register keeps historical information on all compa-
nies in Denmark. If a person has been an employee, a
working history stating dates of start and end of each
employment can be retrieved. Records have been kept
even when a person has retired or deceased. Further, each
company has by Statistics Denmark been classified
according to an extended version of International Stand-
ard Industrial Classification of all economic activities,
which includes detailed information on trades where
exposure to wood dust is normal, e.g. wood furniture
industry or carpentry shops, etc. Based on this informa-
tion we reconstructed the employment- and potential
wood dust exposure history from 1964 and until diagno-
sis. We also extracted a job title from the Central Person
Registry and classified this according to potential wood
dust exposure. Finally, we obtained information on occu-
pational exposure to risk factors for sinonasal carcinomas
including wood dust, tobacco smoking, formaldehyde,
chromium(VI), nickel, textile and leather dust by a struc-
tured telephone interview either with the patient or if he
or she was deceased with a next-of-kin, preferable the last
spouse or a child. Information on vital status, relatives
and contact addresses was obtained from the CPR-regis-
try. The CPR-registry, which we used to identify contact
addresses on patients, their spouses and children, was
established in 1968 and included all persons alive from
the first of April 1968 until today. Family relations were,
at the onset of the CPR register presumed to be the per-
sons living at the same address. Therefore, for the link
between parents and their children, the CPR register is
only regarded complete for persons born in 1930 and
onwards. However, information before 1930 still exists in
the registry, but is of more sporadic character. Since, the
majority of our cases with sinonasal cancer (n = 103) was
born before 1930, and had already died at the onset of
this study, cases for whom we could identify relatives to
contact, were primarily limited to those born after 1930.
Among the 103 patients born before 1930, a contact per-
son could only be identified for 31 patients (25 of these
completed an interview). For the 71 patients born after
1930 a contact person could be identified for 67 persons
(60 of these completed an interview). In total 85 inter-
views were successfully completed.
DNA purification
Genomic DNA was prepared from five 10-μm sections.
The sections were extracted twice with 1 ml xylene
(Merck) and twice with 1 ml 96% ethanol, each for 10
min at 55°C with centrifugation in between. After the last
wash with ethanol, the tissue was dried and rehydrated
with 500 μl lysis buffer (50 mM Tris-HCl pH 8.5, 1.0 mM
EDTA, 0.5% Tween-20) for 2 hours (55°C) under rota-
tion. The tissue was agitated with 50–100 μl 20 mg/ml
proteinase K (Finnzymes, Finland) depending on sample
size, overnight or until the tissue was totally degraded. The
samples were extracted twice with 500 μl phenol/chloro-
form/water mixture (Applied Biosystems, cat. no 400765)
and once with 500 μl chloroform (AMRESCO, Ohio, US).
The DNA was precipitated for 2 hours at -20°C with 27 μl
3 M sodium acetate in ice-cold ethanol. The DNA was
washed once with 70% ethanol, and dried at 50°C before
it was dissolved in RNase free water. The DNA concentra-
tion was determined spectrophotometrically at 260 and
280 nm, and where possible, the concentration was
adjusted to 100 μg/ml.
RFLP analyses
In order to identify mutations in the K-ras gene codon 12,
codon 13 and codon 61, three assays were developed. The
assays were modified versions of the methods used by
Saber et al [20] and Vachtenheim et al [24]. Separate PCR
reactions were performed for the three assays. The reac-
tions were performed with the primers listed in Table 2
under the conditions listed in Table 3, the amount of
DNA varied from 0.5 μl to 4 μl since individual optimiza-
tion for each sample was necessary.
The PCR reactions were carried out on a PTC-100™ Pro-
grammable Thermal Controller (MJ Research, Inc). The
cycling conditions for the RFLP12 assay and the RFLP13
assay were; denaturation at 94°C for 1 min, taken though
35 cycles at 94°C for 30 sec, 55°C for 45 sec, 72°C for 45
sec and a final incubation at 72°C for 10 min. For the
RFLP61 assay the cycling conditions were: DNA was dena-
tured at 94°C for 2 min, the reactions were taken through
12 cycles of 94°C for 30 sec and 67°C for 1 min with a
decrement of -1°C for each cycle (67°C to 56°C), then
taken through 28 cycles of 94°C for 40 sec, 56°C for 1
min and finally incubated at 72°C for 10 minutes. For all
PCR reactions a no template control was included. All
PCR products were visualised on a 1.5% NuSieve® 3:1 aga-
rose gel, and only samples where a distinct band of the
correct size was observed were used for restriction enzyme
digestion.
Before restriction enzyme digestion, the PCR products for
the RFLP13 assay were purified by GFX PCR DNA and Gel
Band Purification Kit (Amersham Biosciences, UK). The
restriction enzyme digestion of the RFLP12 assay was per-
formed with 10 μl PCR product, 1× NEBuffer 2, 100 μg/
ml BSA and 10 units of restriction endonuclease BstN1 I
(Biolabs, New England), incubated overnight at 60°C.
The digestion of the RFLP13 assay was performed in aPage 4 of 11
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of restriction endonuclease Van 91 I (Boeringer Man-
heim) with 6 hr of incubation at 37°C. The RFLP61 assay
was digested in a total volume of 11.6 μl with 1× NEBuffer
2 and 6 units of restriction endonuclease Bcl I (Biolabs,
New England) and 6 hr incubation at 50°C. The digested
PCR fragments were visualised on a 3% NuSieve® 3:1 aga-
rose gel, run in 1× TBE buffer.
To ensure that we were able to distinguish between a
mutant sequence and wild type sequence, we included a
negative and a positive control in all digestions. As a neg-
ative control, DNA from a healthy person was used. For
positive controls in the codon 12 assay the A549 cell line,
which contains a homozygous GGT→ AGT mutation was
used [25]. For codon 13 the MDA-MB231 cell line with a
heterozygous GGC→GAT mutation [26] was used and for
codon 61 DNA from a cancer patient with a heterozygous
CAA→ CTA mutation was used. To determine the sensitiv-
ity of the assays, mutated DNA was diluted with wild type
DNA. In the assay RFLP12, a distinct band of mutated
PCR products was detected in a mixture containing 6.25
% homozygote DNA which corresponds to 12.5 %
tumour tissue assuming a dominant mutation. In the
other two assays, the RFLP13 and RFLP61, bands of
mutated PCR product were detected with 12.5% mutated
heterozygous DNA. A clear cut detection of mutations was
therefore possible in samples with a tumour content of 10
% and above in the RFLP assays. Using direct sequencing,
a mutation could be detected in samples containing 12.5
% mutated DNA which corresponds to 25 % tumour tis-
sue heterozygous for mutation in a sample (data not
shown).
Direct sequencing
In order to identify the mutations by direct sequencing,
two assays were developed, the SEQ1213, SEQ61. In order
to generate PCR products for sequencing the following
primers were developed; forward1213 5' AAC CTT ATG
TGT GAC ATG TTC'3, reverse1213 5' ATG GTC CTG CAC
CAG TAA T'3, forward61 5' AAA GGT GCA CTG TAA TAA
TCC'3 and reverse61 5' TGA TTT AGT ATT ATT TAT GGC
AAA'3. The PCR conditions are listed in Table 3. The PCR
reactions were performed in 50 μl reactions, on a PTC-
100™ Programmable Thermal Controller (MJ Research,
Inc). For the SEQ1213 assay the DNA was denatured at
94°C for 1 min, and amplified in 12 cycles of 94°C for 30
sec and 57°C for 1 min with decrement of -1°C for each
cycle (57°C to 45°C). It was amplified through 28 cycles
of 94°C for 40 sec, 45°C for 1 min and incubated for
72°C for 10 minutes. For the SEQ61 assay the amplifica-
tion was done at: 95°C for 2 min then 40 cycles of 94°C
for 1 min, 48°C for 30 sec and 72°C for 1 min. For all PCR
reactions a control without template was included. The
PCR products (3.0 μl) were visualised by electrophoresis,
on a 1.5% NuSieve® 3:1 agarose gel, run in 1×TBE buffer.
Only PCR reactions where a distinct band in the right size
appeared were purified using the GFX PCR DNA and Gel
Table 2: Primers and restriction enzymes used in the RFLP assays.
Exon Codon Primers Sequence 5' to 3' Restriction enzymes/recognition site PCR product/cut fragments
1 12 RFLP12F ACT GAA TAT AAA CTT GTG GTA GTT 
GGA CCT
BstN I :
5'..CCTGG..3'
3'..GGACC..5'
157 bp/
N: 114+29+14
M:143+14
RFLP1213R TCA AAG AAT GGT CCT GGA CC
1 13 RFLP13F ATA TAA ACT TGT GGT AGT TCC AGC 
TGG
Van 91 I :
5'.CCA(N)5TGG.3'
3'.GGT(N)5ACC.5'
152 bp/
N:126+26
M:152
RFLP1213R TCA AAG AAT GGT CCT GGA CC
2 61 RFLP61F CTT GGA TAT TCT CGA CAC AGC TGA T Bcl I:
5'..TGATCA..3'
3'..ACTAGT..5'
179 bp/
N:155
M: 179
RFLP61R AAC TAT AAT TAC TCC TTA ATG TCA GCT 
TA
Table 3: Reaction conditions for all the PCR reactions.
Assay\PCR conditions KCl Tris-HCl MgCl2 dNTP Taq polymerase Primers forward + reverse pH
RFLP12 50 mM 20 nM 0.25 mM 0.2 mM 0.75 unit 0.5 μM 8.4
RFLP13 50 mM 20 nM 0.25 mM 0.2 mM 0.75 unit 0.5 μM 8.4
RFLP61 50 mM 10 nM 1.5 mM 0.2 mM 1.0 unit 1.0 μM 8.3
SEQ1213 50 mM 10 nM 1.5 mM 0.2 mM 1.0 unit 1.0 μM 9.0
SEQ61 50 mM 10 nM 1.5 mM 0.2 mM 1.0 unit 1.0 μM 9.0Page 5 of 11
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according to the manufacturer. To generate the sequenc-
ing templates for the SEQ1213 and 61 the following prim-
ers were used; sequence1213 5' ATA TAG TCA CAT TTT
CAT TAT T'3 and sequence61 5'TGT TTC TCC CTT CTC
AGG ATT C'3 with the BigDye® Terminator Ready Reac-
tion Kit (Applied Biosystems, part no 4303152) according
to the manufacturer. The annealing temperatures were
SEQ1213, 45°C and SEQ61, 50°C. The sequencing was
performed on an ABI 310 Genetic Analyser, according to
standard protocols. In order to confirm a mutation, both
strands were sequenced a second time from an independ-
ent PCR reaction.
Statistical analysis
In this case-case study we compared historical occupa-
tional exposure to wood dust in cases with different histo-
logical types of sinonasal cancers, using squamous cell
carcinoma cases as a reference group. We also compared
this exposure to wood dust of the cases with and without
K-ras mutations. To estimate the magnitude of the associ-
ations, multivariate adjusted odds ratios and their corre-
sponding 95% confidence intervals were calculated by
unconditional logistic regression with the statistical pack-
age Stata, version 9. Age and sex were included in all mod-
els as potential confounders. In the subgroup of 85 cases
for which we have individual information on tobacco
smoking and occupational exposure to formaldehyde,
these were further included in the models. None of the
cases with tumours with K-ras mutations were exposed to
other potential confounders, i.e. leather and textile dust,
nickel and chromium(VI).
Results
Histology and wood dust exposure
The histological diagnoses included in the study and the
number of patients in each category is listed in Table 1.
The study included 58 adenocarcinomas, 109 squamous
cell carcinomas and 7 carcinomas of other types. A com-
pilation of our assessment is listed in Table 1. Based on
our criteria for interview we contacted 97 patients by mail.
Interview of the patients were completed for 85 patients
(34 adenocarcinomas, 48 squamous cell carcinomas and
3 with other histology). Seven patients refrained from par-
ticipating in the study (5 with adenocarcinomas and 2
with squamous cell carcinomas) (Table 4). The last 6
patients could not be reached. In the interviews, 65% of
the adenocarcinoma patients (22 patients) reported expo-
sure to wood dust. In the squamous cell carcinoma group
only 15 % (7 patients) reported that they had been
exposed to wood dust. When we evaluated all available
exposure data, we concluded that totally 40 patients
(23%) had been exposed to wood dust, none of these
being women. Thirty-three of the wood dust exposed
patients had been diagnosed with adenocarcinomas and
seven with squamous cell carcinomas. The frequency of
wood dust exposure was 8.9 times more common in the
group of adenocarcinomas (33 out of 58 patients were
exposed to wood dust) compared to squamous cell carci-
nomas (7 out of 109 patients were exposed to wood dust).
Among our patients exposure to wood dust was associated
with a 21-fold [CI = 8.0–55.0] increased risk of having an
adenocarcinoma than a squamous cell carcinoma com-
pared to patients not being exposed, when adjusting for
age. For those 85 patients that had been interviewed it was
possible to investigate the influence of smoking and occu-
pational confounders. Information on both smoking and
formaldehyde was available for only 82 of the interviewed
patients. In this limited group of patients wood dust expo-
sure was associated with a 47-fold [CI = 7.7–328]
increased risk of adenocarcinomas than squamous cell
carcinomas compared to unexposed cases, when adjusting
for age, tobacco smoking and formaldehyde exposure
(Table 5).
Table 4: Distribution of exposure to wood dust in relation to histological diagnosis of sinonasal cancers.
Wood dust exposure crude Males Females
Squamous cell carcinoma Adenocarcinoma Other Squamous cell carcinoma Adenocarcinoma Other
No exposure (interview) 19 3 1 22 2 2
No exposure according to registers 32 12 4 29 8 0
Wood dust exposure confirmed by 
interview
6 29 0 - - -
Wood dust exposure according to 
registers
1 4 0 - - -
Total 58 48 5 51 10 2
The wood dust exposure is based on information from three sources: 1, personal interview, 2, trade and job codes from the National Pension Fund 
(NPF) and 3, self reported job titles in Central Person Registry (CPR). A minimum employment length of one year was set as a lower limit. If a patient's 
data from NPF or CPR did not imply any wood dust related employments the patient was considered not exposed to wood dust. Patients without any 
records in NPF and CPR are also regarded as not exposed since they have not been an employee and therefore unlikely to be exposed to wood dust. 
The information from the interview was weighted more important than that in the data retrieved from the two registers. The patients in the rows of no 
exposure confirmed by interview and no exposure according to registers are referred to as not exposed to wood dust. The patients in the rows wood 
dust exposure confirmed by interview and wood dust exposure according to registers are categorized as exposed to wood dust.Page 6 of 11
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The analysis of K-ras codon 12, mutations was successful
with at least one of the assays for 166 of the samples
(95%), whereas for the rest of the samples, no PCR prod-
uct could be amplified despite several attempts. For codon
13, the success rate was 90 % (157 samples). For codon
61, only the adenocarcinoma samples were analysed by
RFLP, with a success rate of 88%. However, direct
sequencing was performed on all samples, with a success
rate on 91%. Only mutations in codon 12 and 13 were
found. The mutations and exposure data for these patients
are presented in Table 6
We identified 8 mutations in total. Three of these were
ambiguous since a clear-cut sequencing result could not
be obtained due to high background. Of the eight muta-
tions, seven occurred in adenocarcinomas, only one
occurred in a squamous cell carcinoma. The identified
mutations were all located in codon 12. Three were G•C
→ A•T transitions causing an amino acid change from gly-
cine to aspartic acid. In one patient a G•C → C•G trans-
version was identified leading to an amino acid change
from glycine to alanine and finally, in one patient a G•C
→ T•A transversion had occurred changing glycine to
valine.
The exposure to wood dust was assessed by interviews and
data extracted from the Central Person Registry (CPR) and
National Pension Fund (NPF). Patient number 15, har-
bouring a mutation in codon 12 (GGTGLY → GATASP)
refrained from being interviewed, no job title was regis-
tered in the CPR nor was there a record of employment in
the pension fund, making it likely that she has been full-
time housewife. The RFLP on samples from patient 64, 76
and 160 indicated mutations. However, the sequencing of
the samples could not confirm a mutation despite several
sequencing attempts. Patient number 64 reported that he
had been a furniture worker/construction carpenter for 37
years. Patient number 76 had worked from a young age as
a furniture maker for 47 years with only a few interrup-
tions. Patient number 160 was not classified as having
been exposed to wood dust, but had several jobs servicing
Table 6: Lists the histology, exposure data and mutations from sinonasal patients harbouring K-ras mutations.
Patient Most recent job title 
according to the Central 
person registry
Histology Interview Smoking Other potential 
confunders
Wood dust exposure 
according to interview
Mutation
15 - High-grade 
Adenocarcinoma
No NA NA No GGT→GAT
64 Master joiner Low-grade 
Adenocarcinoma
Yes No Formaldehyde Yes Ambiguous (codon 12 
3rd or codon 13, nt 1 
or 2)
76 Master joiner Intestinal-type 
Adenocarcinoma
Yes Yes Formaldehyde Yes Ambiguous 
(GGC→GAC)
86 Master joiner Low-grade 
Adenocarcinoma
Yes Yes Formaldehyde Yes GGT→GAT
91 Farmer Intestinal-type 
Adenocarcinoma
Yes Yes No Yes GGT→GAT
93 Long distance driver Squamos cell 
carcinoma
Yes Yes No No GGT→GCT
160 Worker Low-grade 
Adenocarcinoma
Yes Yes No No Ambiguous (codon 12, 
nt 1 or 2)
178 Associate professor Low-grade 
Adenocarcinoma
Yes No No No GGT→GTT
NA = data not available, since no interview was completed. Wood dust exposure is based on information from interview. Where interview data was not 
available trade and job codes from the National Pension Fund (NPF) or self reported job titles in Central Person Registry (CPR) were used. A minimum 
employment length of one year was set as a lower limit. Patients without any records in NPF and CPR are also regarded as not exposed since they have 
not been an employee and therefore unlikely to be exposed to wood dust. The information from the interview was weighted more important than that 
in the data retrieved from the two registers.
Table 5: Exposure to wood dust by cases with squamous cell carcinomas and adenocarcinomas
Histology Wood dust Yes/no OR1 (95%CI) OR2 (95%CI) OR3 (95%CI)
Squamous cell carcinomas 7/102 1 1 1
Adenocarcinomas 33/25 19.2 (7.6–48.5) 21.0 (8.0–55.0) 46.9 (7.7–328)
1) Unadjusted
2) adjusted for age
3) adjusted for age, formaldehyde and tobacco smoking, but data limited to the subgroup of patients (n = 82) for which an interview was completed and 
information on tobacco smoking and formaldehyde was present (squamous cell: wood dust exposed = 6, not exposed = 41; adenocarcinomas: exposed 
= 29, not exposed = 6)Page 7 of 11
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patients number 86 and 91 both had a mutation in codon
12 (GGTGLY → GATASP). Patient number 86 reported
working as a furniture maker for 19 years, before being
employed in an administrative job. Patient number 91
worked mainly with farming and had part time employ-
ment as a bricklayer (8-years) and a truck driver at a saw
mill (12-years). He was classified as being exposed to
wood dust. For patient number 93 a codon 12 (GGTGLY →
GCTALA) mutation was observed. The patient's occupa-
tional history, of working as a farm helper, trench-digging
machine operator and a long distance van driver, did not
reflect exposure to wood dust. Tumour tissue from patient
number 178 also contained a mutation in codon 12
(GGTGLY → GTTVAL), and he was also classified as not hav-
ing been exposed to wood dust. The patient reported in
the interview had been working as a clerk in the shipping
trade and as a higher education teacher. According to the
interviews, patients number 76, 86, 9, 93 and 160 were
smokers, whereas patients number 64 and 178 were never
smokers. Odds ratios for tobacco smoking and formalde-
hyde adjusted for age and sex are shown in Table 7 for the
subgroup of interviewed patients. There was an ORunad-
justed of 3.6 [CI = 0.9–15.2] for having a K-ras mutation
among those who had been exposed to wood dust com-
pared to those who had not been exposed. This odds ratio
decreased to 2.0 [CI = 0.2–16.5] after adjustment for
potential confounders
We determined the sensitivity of the assays by diluting
mutated DNA with wild type DNA. In the diluted positive
controls we were able to detect mutations, corresponding
to samples containing 12.5% tumour material harbouring
a heterozygous K-ras mutation in the RFLP analysis. There
was somewhat less sensitivity than with direct sequencing,
but mutations could be detected in samples correspond-
ing to 25% tumour tissue. The average amount of cancer
tissue in the blocks was 51% with a standard deviation of
24% and a minimum content of 10%.
Discussion
Cancers of the sinonasal cavities are strongly correlated to
exposure to wood dust, in particular adenocarcinoma has
been associated with exposure to hardwood dust in epide-
miological studies [3-5,7]. In the present study, we found
that 23% of the patients had been exposed to wood dust.
It has recently been estimated that 3.3% of the employed
population in Denmark are exposed to wood dust [27]. In
our study exposure to wood dust adjusted for age was
associated with a 21.0-fold [CI = 8.0–55.0] increase in the
risk of having an adenocarcinoma than a squamous cell
carcinoma. The frequency of wood dust exposure among
the patients with adenocarcinomas was 8.9 times more
common than among the patients with squamous cell car-
cinomas. Our findings are some what in accordance with
a previously published pooled analysis on eight case/con-
trol studies by Mannetje et al [28]. In this analysis the fre-
quency of wood dust exposed adenocarcinomas (74.2%)
were five times more common than wood dust exposed
squamous cell carcinomas (14.7%).
Table 7: Exposure to wood dust, tobacco smoking and formaldehyde in sinonasal cancer cases with and without K-ras mutations.
K-ras mutations
Characteristics Total Mutation/wild type OR1 (95%CI) OR2 (95%CI)
Wood dust exposure
No 134 4/130 1 1
Yes 40 4/36 3.6 (0.9–15.2) 2.0 (0.2–16.5)
Age 174 8/166 0.97 (0.92–1.02) 1.0 (0.9–1.1)
Sex
Male 111 7/104 1 1
Female 63 1/62 0.2 (0.03–2) 0.3 (0.03–3.1)
Tobacco smoking
No 15 2/13 1 1
Yes 69 5/64 0.5 (0.1–2.9) 0.4 (0.1–2.6)
Unknown 90 1/89 0.1 (0.001–0.9) -
Formaldehyde exposure
No 50 4/46 1 1
Yes 35 3/32 1.1 (0.2–5.1) 0.5 (0.1–3.9)
Unknown 89 1/88 0.1 (0.01–1.2) -
The table shows the influence on sex, age and exposure to tobacco smoking, and formaldehyde to the odds ratios for having a K-ras mutation. 
Information on exposures was based on interview and registry data. Information on smoking and exposure to formaldehyde could only be obtained 
from interviewed persons, which explains the number of persons with unknown status. 1 Unadjusted odds ratio, 2 Mutually adjusted odds ratio.Page 8 of 11
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detected in 13% of the adenocarcinomas and in 1% of the
squamous cell carcinomas. The found frequency of K-ras
mutations was lower than expected. Due to the low fre-
quency of K-ras mutations, even in this large study, there
was not sufficient statistical power to detect statistically
significant associations, if they exist. However, the study
was conducted to include all cases of relevant sinonasal
cancers in Denmark with in a reasonable time frame for
conducting interview of the cases. The odds ratios in this
study were influenced by some uncertainty, because some
calculations were made on groups with less than 10 indi-
viduals.
We found an odds ratio for a non significant association
between wood dust and K-ras mutation on 3.6 [CI =
0.9–15.2] Taking into consideration formaldehyde and
smoking reduced the odds ratio (Table 7). However, the
mutation frequency in adenocarcinomas were similar to
those reported in the studies of Saber et al [20] and Yom
et al [21], but it is lower than in a study by Frattini et al
[23], who reported of a frequency of 50 % in 17 intestinal
type adenocarcinomas from Italian patients. This was not
explained by differences in the detection methods used.
The sensitivity of the assays in the combination used
should be sufficient to identify mutations in the sinonasal
tumours. The differences in the prevalence of mutations
might be related to differences in the type of exposures.
For example hardwoods are used more frequently in Italy
(55% of the wood consumed) compared to Northern
European countries (8–21% of the wood consumed) [29].
The most frequently found mutation in this study was the
GGTGLY → GATASP transitions, which were found in 3 out
of 5 mutations. The GGT→GAT transition has been asso-
ciated with a bad prognosis in studies of lung adenocarci-
nomas [30,31]. It is also the most common among the
previously published K-ras codon 12 and 13 mutations in
sinonasal cancers. In the study by Saber et al [20], two out
of four mutations were GAT transitions, and both were in
wood dust exposed patients. In the study by Frattini et al
[23], nine mutations were identified. Eight of these were
GAT transitions, three of which were from wood dust
exposed patients. The remaining one, a GGTGLY → AGTSER,
was from a wood dust exposed patient as well. In the
study by Perez et al [19] one mutation in the K-ras gene, a
GAT transition from a wood dust exposed patient was
identified.
Summarising mutation data from the present study and
previously published ones, it appears that cancers har-
bouring K-ras mutations represent a small fraction of the
sinonasal adenocarcinomas. The mutations were prima-
rily located (16/20) at codon 12, and 85% of them were
G→A transitions (17/20). All though the number is small,
the high frequency of G→A transitions may suggest an
environmental component involved in this subgroup of
sinonasal cancers. In acute myeloid leukaemia increased
frequency of activated ras genes identified a subgroup
associated with occupational or chemical exposure [32].
The G→A transitions are typically produced by alkylating
agents in experimental systems, consistent with O6-
methyl-guanine-misparing [33,34]. In humans this transi-
tion has been identified in human liver tumours after
exposure to vinyl chloride [35,36]. The G→A base transi-
tions in K-ras are also very frequently identified in rodent
lung neoplasms after long-term exposures to N-nitroso
compounds [37]. In tobacco-related lung adenocarcino-
mas of humans G→T transversions are the most frequent
mutations, but G→A transitions are second most frequent
[38,39] and most frequent among non smokers [15]. After
chronic inhalation to mainstream cigarette smoke in rats
the two identified mutations were G→A transitions and
G→T transversions [40].
The combination of a G→A transition and exposure to
wood dust was present among 60% (9/15) of the G→A
mutations where the patient's occupational exposure was
known. The frequency of G→A transitions did not differ
between wood dust exposed patients and non-exposed
(Fisher exact, P = 0.25) However, genotoxic effects have
been detected in several studies of healthy wood workers
[41-43] and wood dusts were tested positive in the comet
assay in the human lung epithelial cell line A549 before
an the inflammatory reaction was evoked [44,43].
In addition, in the present study, the two patients with
G→A transitions were both smokers. In the study by Saber
et al [20], two of the three patients with G→A transitions
were smokers. Since exposure to tobacco smoke carcino-
gens is also associated with G→A transitions, smoking,
including involuntary smoking, may also play a role in
the carcinogenesis of this subpopulation of sinonasal can-
cers. To determine the mechanisms behind the carcino-
genesis induced by a potential synergistic effects of
smoking and wood dust in this subpopulation of sinona-
sal cancers more studies are needed. Because of the diffi-
culty in achieving statistical power in molecular
epidemiology studies of this type cancer, due to the rarity
of both sinonasal cancer and K-ras mutations, it might be
more effective to study the mutagenesis of wood dust in
experimental studies.
Conclusion
We sought to investigate whether exposure to wood dust
was associated with a specific mutational pattern in the K-
ras gene in a large, representative study population. We
therefore examined all incident cases of sinonasal cancer
in Denmark 1991–2001. Wood dust exposure occurred inPage 9 of 11
(page number not for citation purposes)
BMC Cancer 2008, 8:53 http://www.biomedcentral.com/1471-2407/8/5323% of our patients and was associated with a 21-fold [CI
= 8.0–55.0] increase in the risk for having an adenocarci-
noma than a squamous cell carcinoma compared to not
being exposed. The frequency of K-ras mutations in aden-
ocarcinoma (13%) was in the range reported in earlier
studies, whereas the frequency was very low in the squa-
mous cell carcinoma (1%). Collectively, taking into
account the mutations we detected our and the ones in
sinonasal cancers that have been reported before, the
GGTGLY → GATASP transition is the most common muta-
tion after exposure to wood dust. In conclusion, muta-
tional activation of K-ras in SNC is restricted to a subgroup
of the adenocarcinoma histology. However, since most of
the mutation positive cases were smokers, active or pas-
sive exposure to cigarette smoke, may also be involved.
The observed mutation types are in keeping with this.
Overall, the study suggests a limited role for K-ras muta-
tions in development of sinonasal cancer.
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